Global Excellence Research seminar XX
Peter Laing (Excivion Ltd, Cambridge, UK)
A novel flavivirus vaccine platform designed to avoid antibody-dependent enhancement of infection
Peter Laing (Excivion Ltd, Cambridge, UK)A novel flavivirus vaccine platform designed to avoid antibody-dependent enhancement of infection